BioSpace News Archive

With an innovation that could inject new life into the global digital-camera market, CEA-Leti will demonstrate its new technology for image sensors at CES 2019 that replicates the curve of the human retina.

In its annual review of medical and scientific discoveries, the publication Reader’s Digest named DotLab as one of the “Amazing Medical Breakthroughs of 2018.” DotLab is recognized for its DotEndo product - the world’s first-ever, non-invasive test for endometriosis.

The forces leading to detachment and depersonalization among burned-out primary care physicians are similar to the factors responsible for populist movements—the perception of a rigged system favoring a managerial elite, according to a commentary in the December issue of The American Journal of Managed Care. ®

Maryland University of Integrative Health (MUIH) and Leadership Maryland announced today that Steven C. “Steve” Combs, Ph.D., President and CEO of MUIH, has completed the professional development program dedicated to building a better Maryland by harnessing the strength of its local business and community leaders

Further to its news release of November 27, 2018, Portage Biotech Inc. (“Portage” or the “Company”) is pleased to announce that its common shares will resume trading at the open on CSE tomorrow, December 7, 2018 with trading on OTC expected to resume shortly thereafter.

Activation Clinic is making waves in the medical world of sexual wellness by joining the GAINSWave® movement to offer GAINSWave treatment!

FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today announced the appointment of Maykin Ho, Ph.D., as an independent director to FibroGen’s Board of Directors.

Clinical research and technology leaders from across the industry will share their data and expertise at an upcoming webinar hosted by CRF Health, a CRF Bracket company, to discuss how to improve patient centricity through electronic informed consent (eConsent).

Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.

Now Helping both Men AND Women with Age Management Services